Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis

Affiliations

• ¹ Neurology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
• ² Immunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
• ³ Neurology Department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
• ⁴ Neurology Department, Hospital Universitario La Princesa, Madrid, Spain.
• ⁵ Neurology Department, Hospital Universitario Juan Ramon Jimenez, Huelva, Spain.
• ⁶ Neurology Department, Hospital Universitario de Gerona Doctor Josep Trueta, Gerona, Spain.
• ⁷ Neurology Department, Hospital Universitario de Bellvitge, Barcelona, Spain.
• ⁸ Neurology Department, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain.
• ⁹ Neurology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
• ¹⁰ Neurology Department, Hospital Universitario Gran Canaria Doctor Negrín, Gran Canaria, Spain.
• ¹¹ Neurology Department, Hospital Universitario Clínico San Cecilio Granada, Granada, Spain.
• ¹² Neurology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
• ¹³ Neurology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
• ¹⁴ Neurology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
• ¹⁵ Neurology Department, Hospital Universitario Joan XXII, Tarragona, Spain.
• ¹⁶ Neurology Department, Complejo Asistencial de Ávila, Ávila, Spain.
• ¹⁷ Neurology Department, Hospital Virgen del Puerto, Cáceres, Spain.
• ¹⁸ Neurology Department, Hospital Universitario Principe de Asturias, Madrid, Spain.
• ¹⁹ Neurology Department, Hospital Universitario Nuestra Señora Candelaria, Tenerife, Spain.
• ²⁰ Neurology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
• ²¹ Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
• ²² Biostatistics Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.